title: Deprenyl and levodopa and Parkinson's disease progression.
authors.forename: J S
authors.initials: JS
authors.lastname: Fowler
authors.forename: E
authors.initials: E
authors.lastname: Fazzini
authors.forename: N D
authors.initials: ND
authors.lastname: Volkow
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008995:Monoamine Oxidase / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000978:Antiparkinson Agents; D012642:Selegiline; D007980:Levodopa; D008995:Monoamine Oxidase